Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Simvastatin - Merck & Co

Next Previous
X
Search
Drug Profile

Simvastatin - Merck & Co

Alternative Names: Belmalip; Colemin; Denan; L-644128-000U; Lipex; Liponorm; Lipovas; Lodales; Medipo; MK-733; Pantok; Sinvacor; Sivastin; Synvinolin; Velastatin; Zocor; Zocord

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medical University of South Carolina; Merck Sharp & Dohme
  • Developer Cystic Fibrosis Foundation Therapeutics; Merck & Co; Merck Sharp & Dohme; Sahlgrenska University Hospital; University of Tokyo
  • Class Antihyperlipidaemics; Naphthalenes; Small molecules
  • Mechanism of Action HMG-CoA reductase inhibitors; Nitric oxide synthase type II inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Diabetic cardiomyopathy; Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertriglyceridaemia; Low HDL cholesterol
  • No development reported Cystic fibrosis
  • Discontinued Alzheimer's disease; Bone resorption; Rheumatoid arthritis

Most Recent Events

  • 27 Jul 2022 Lacer has been acquired by Italfarmaco
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Cystic-fibrosis in USA (PO, Tablet)
  • 01 Mar 2017 University College London initiates the phase III MS-STAT2 trial for Multiple sclerosis in United Kingdom

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top